Free Trial

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Short Interest Update

DENTSPLY SIRONA logo with Medical background
Remove Ads

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 10,570,000 shares, a growth of 31.1% from the February 28th total of 8,060,000 shares. Approximately 5.4% of the company's shares are short sold. Based on an average daily trading volume, of 2,870,000 shares, the short-interest ratio is presently 3.7 days.

Analyst Ratings Changes

Several analysts have issued reports on the company. Barrington Research dropped their target price on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Evercore ISI restated an "in-line" rating and issued a $20.00 target price on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Mizuho lowered their price target on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and decreased their price target for the stock from $30.00 to $20.00 in a report on Thursday, January 23rd. Finally, StockNews.com lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Twelve equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and an average price target of $23.33.

Remove Ads

Get Our Latest Research Report on DENTSPLY SIRONA

Insider Buying and Selling

In other news, Director Gregory T. Lucier purchased 15,142 shares of the business's stock in a transaction dated Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the purchase, the director now owns 81,971 shares in the company, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through this link. 0.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC grew its holdings in DENTSPLY SIRONA by 2.5% in the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock valued at $275,218,000 after buying an additional 348,532 shares in the last quarter. Nuance Investments LLC increased its stake in shares of DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock worth $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in shares of DENTSPLY SIRONA by 18.7% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock worth $238,186,000 after acquiring an additional 1,975,404 shares during the period. Finally, Fuller & Thaler Asset Management Inc. grew its holdings in shares of DENTSPLY SIRONA by 2.8% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock valued at $219,018,000 after purchasing an additional 314,343 shares during the period. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Price Performance

XRAY stock traded down $1.17 during midday trading on Thursday, reaching $13.70. The stock had a trading volume of 415,127 shares, compared to its average volume of 2,759,520. DENTSPLY SIRONA has a 52-week low of $13.64 and a 52-week high of $33.02. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company's fifty day simple moving average is $17.37 and its 200 day simple moving average is $19.93. The company has a market cap of $2.73 billion, a price-to-earnings ratio of -6.62, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98.

DENTSPLY SIRONA Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 4.67%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio is currently -14.07%.

DENTSPLY SIRONA Company Profile

(Get Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Read More

Should You Invest $1,000 in DENTSPLY SIRONA Right Now?

Before you consider DENTSPLY SIRONA, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.

While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

Donald Trump Owns These 7 Stocks, Should You?
 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads